These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 35244192)
1. LncCCAT1 interaction protein PKM2 upregulates SREBP2 phosphorylation to promote osteosarcoma tumorigenesis by enhancing the Warburg effect and lipogenesis. Pu F; Liu J; Jing D; Chen F; Huang X; Shi D; Wu W; Lin H; Zhao L; Zhang Z; Lv X; Wang B; Zhang Z; Shao Z Int J Oncol; 2022 Apr; 60(4):. PubMed ID: 35244192 [TBL] [Abstract][Full Text] [Related]
2. Pyruvate kinase M2 interacts with nuclear sterol regulatory element-binding protein 1a and thereby activates lipogenesis and cell proliferation in hepatocellular carcinoma. Zhao X; Zhao L; Yang H; Li J; Min X; Yang F; Liu J; Huang G J Biol Chem; 2018 Apr; 293(17):6623-6634. PubMed ID: 29514980 [TBL] [Abstract][Full Text] [Related]
3. A novel miR-206/hnRNPA1/PKM2 axis reshapes the Warburg effect to suppress colon cancer growth. Fu R; Yang P; Amin S; Li Z Biochem Biophys Res Commun; 2020 Oct; 531(4):465-471. PubMed ID: 32800545 [TBL] [Abstract][Full Text] [Related]
4. Knockdown of pyruvate kinase type M2 suppresses tumor survival and invasion in osteosarcoma cells both in vitro and in vivo. Yuan Q; Yu H; Chen J; Song X; Sun L Exp Cell Res; 2018 Jan; 362(1):209-216. PubMed ID: 29155364 [TBL] [Abstract][Full Text] [Related]
5. The responsively decreased PKM2 facilitates the survival of pancreatic cancer cells in hypoglucose. Li X; Deng S; Liu M; Jin Y; Zhu S; Deng S; Chen J; He C; Qin Q; Wang C; Zhao G Cell Death Dis; 2018 Jan; 9(2):133. PubMed ID: 29374159 [TBL] [Abstract][Full Text] [Related]
6. Pyruvate kinase type M2 contributes to the development of pancreatic ductal adenocarcinoma by regulating the production of metabolites and reactive oxygen species. Yokoyama M; Tanuma N; Shibuya R; Shiroki T; Abue M; Yamamoto K; Miura K; Yamaguchi K; Sato I; Tamai K; Satoh K Int J Oncol; 2018 Mar; 52(3):881-891. PubMed ID: 29393401 [TBL] [Abstract][Full Text] [Related]
7. Ginsenoside 20(S)-Rg3 Prevents PKM2-Targeting miR-324-5p from H19 Sponging to Antagonize the Warburg Effect in Ovarian Cancer Cells. Zheng X; Zhou Y; Chen W; Chen L; Lu J; He F; Li X; Zhao L Cell Physiol Biochem; 2018; 51(3):1340-1353. PubMed ID: 30481782 [TBL] [Abstract][Full Text] [Related]
8. ULK1-dependent phosphorylation of PKM2 antagonizes O-GlcNAcylation and regulates the Warburg effect in breast cancer. Zhou Z; Zheng X; Zhao J; Yuan A; Lv Z; Shao G; Peng B; Dong MQ; Xu Q; Xu X; Li J Oncogene; 2024 Jun; 43(23):1769-1778. PubMed ID: 38632437 [TBL] [Abstract][Full Text] [Related]
9. ERK1/2-dependent phosphorylation and nuclear translocation of PKM2 promotes the Warburg effect. Yang W; Zheng Y; Xia Y; Ji H; Chen X; Guo F; Lyssiotis CA; Aldape K; Cantley LC; Lu Z Nat Cell Biol; 2012 Dec; 14(12):1295-304. PubMed ID: 23178880 [TBL] [Abstract][Full Text] [Related]
10. Atg7 inhibits Warburg effect by suppressing PKM2 phosphorylation resulting reduced epithelial-mesenchymal transition. Feng Y; Liu J; Guo W; Guan Y; Xu H; Guo Q; Song X; Yi F; Liu T; Zhang W; Dong X; Cao LL; O'Rourke BP; Cao L Int J Biol Sci; 2018; 14(7):775-783. PubMed ID: 29910687 [TBL] [Abstract][Full Text] [Related]
11. The Role of PKM2 in Metabolic Reprogramming: Insights into the Regulatory Roles of Non-Coding RNAs. Puckett DL; Alquraishi M; Chowanadisai W; Bettaieb A Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33503959 [TBL] [Abstract][Full Text] [Related]
12. Epigenetic regulation of the Warburg effect by H2B monoubiquitination. Jing YY; Cai FF; Zhang L; Han J; Yang L; Tang F; Li YB; Chang JF; Sun F; Yang XM; Sun FL; Chen S Cell Death Differ; 2020 May; 27(5):1660-1676. PubMed ID: 31685978 [TBL] [Abstract][Full Text] [Related]
13. Pyruvate kinase M2 (PKM2) in cancer and cancer therapeutics. Zhu S; Guo Y; Zhang X; Liu H; Yin M; Chen X; Peng C Cancer Lett; 2021 Apr; 503():240-248. PubMed ID: 33246091 [TBL] [Abstract][Full Text] [Related]
14. APC loss induces Warburg effect via increased PKM2 transcription in colorectal cancer. Cha PH; Hwang JH; Kwak DK; Koh E; Kim KS; Choi KY Br J Cancer; 2021 Feb; 124(3):634-644. PubMed ID: 33071283 [TBL] [Abstract][Full Text] [Related]
15. Hypoxia-induced lncRNA-AC020978 promotes proliferation and glycolytic metabolism of non-small cell lung cancer by regulating PKM2/HIF-1α axis. Hua Q; Mi B; Xu F; Wen J; Zhao L; Liu J; Huang G Theranostics; 2020; 10(11):4762-4778. PubMed ID: 32308748 [No Abstract] [Full Text] [Related]
16. Expression and clinical significance of pyruvate kinase M2 in breast cancer: A protocol for meta-analysis and bioinformatics validation analysis. Li H; Yan M; Wu X; Wang Y; Huang L Medicine (Baltimore); 2021 May; 100(18):e25545. PubMed ID: 33950928 [TBL] [Abstract][Full Text] [Related]
17. Pyruvate Kinase M2 Modulates Esophageal Squamous Cell Carcinoma Chemotherapy Response by Regulating the Pentose Phosphate Pathway. Fukuda S; Miyata H; Miyazaki Y; Makino T; Takahashi T; Kurokawa Y; Yamasaki M; Nakajima K; Takiguchi S; Mori M; Doki Y Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1461-8. PubMed ID: 25808097 [TBL] [Abstract][Full Text] [Related]
18. Interaction with Pyruvate Kinase M2 Destabilizes Tristetraprolin by Proteasome Degradation and Regulates Cell Proliferation in Breast Cancer. Huang L; Yu Z; Zhang Z; Ma W; Song S; Huang G Sci Rep; 2016 Mar; 6():22449. PubMed ID: 26926077 [TBL] [Abstract][Full Text] [Related]
19. ESM1 enhances fatty acid synthesis and vascular mimicry in ovarian cancer by utilizing the PKM2-dependent warburg effect within the hypoxic tumor microenvironment. Zhang J; Ouyang F; Gao A; Zeng T; Li M; Li H; Zhou W; Gao Q; Tang X; Zhang Q; Ran X; Tian G; Quan X; Tang Z; Zou J; Zeng Y; Long Y; Li Y Mol Cancer; 2024 May; 23(1):94. PubMed ID: 38720298 [TBL] [Abstract][Full Text] [Related]
20. Enhanced expression of the M2 isoform of pyruvate kinase is involved in gastric cancer development by regulating cancer-specific metabolism. Shiroki T; Yokoyama M; Tanuma N; Maejima R; Tamai K; Yamaguchi K; Oikawa T; Noguchi T; Miura K; Fujiya T; Shima H; Sato I; Murata-Kamiya N; Hatakeyama M; Iijima K; Shimosegawa T; Satoh K Cancer Sci; 2017 May; 108(5):931-940. PubMed ID: 28235245 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]